Phenotypic marker for early disease detection in dominant late-onset retinal degeneration

Invest Ophthalmol Vis Sci. 2001 Jul;42(8):1882-90.

Abstract

Purpose: To define early disease expression in autosomal dominant late-onset retinal degeneration (L-ORD), a retinopathy that becomes symptomatic after age 50 and is characterized histopathologically by sub-RPE deposits.

Methods: Three families with L-ORD were included; two families had postmortem eye donors with retina-wide sub-RPE deposits. Six patients with severe visual loss (ages 62-93) were examined clinically, and 17 available individuals (ages 35-60) at a 50:50 risk to inherit L-ORD were also studied with dark adaptometry. A short-term trial of vitamin A at 50,000 IU/day was conducted in three members. Three-year follow-up examinations were performed in a subset of members.

Results: Family 1 had 12 available members at risk. On initial examination, only one member had fundus abnormalities: yellow-white punctate lesions in the midperipheral fundus. Dark-adaptation kinetics were abnormal in 6 of 12. The youngest age with an abnormality was 35. Family 2 had two available members at risk, both of whom had punctate fundus lesions and abnormal dark adaptation. Family 3 had three available members at risk. One had fundus lesions and abnormal dark adaptation, whereas the others had normal fundi and normal adaptometry. Vitamin A accelerated adaptation kinetics but not to normal rates. Three-year follow-up examinations demonstrated further slowing of adaptation kinetics, whereas rod and cone thresholds remained unchanged.

Conclusions: Dark-adaptation abnormalities can precede symptoms and funduscopic signs of L-ORD by at least a decade. Short-term, high-dose vitamin A accelerates the kinetics of dark adaptation to a limited degree. The results contribute clues about early pathophysiology of this retinal degeneration and provide additional power for genetic mapping of the L-ORD locus.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Biomarkers
  • Dark Adaptation / drug effects
  • Dark Adaptation / physiology
  • Electroretinography
  • Female
  • Genes, Dominant
  • Humans
  • Male
  • Middle Aged
  • Pedigree
  • Phenotype
  • Retina / drug effects
  • Retina / pathology*
  • Retina / physiopathology
  • Retinal Degeneration / diagnosis*
  • Retinal Degeneration / genetics
  • Retinal Degeneration / physiopathology
  • Risk Factors
  • Visual Acuity
  • Vitamin A / administration & dosage

Substances

  • Biomarkers
  • Vitamin A